Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.33% | 1.59% | 28.26% | 13.46% | 21.14% |
| Total Depreciation and Amortization | -2.82% | -1.39% | -7.69% | -0.64% | 3.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.10% | 43.39% | -1.17% | -1.58% | -72.08% |
| Change in Net Operating Assets | 758.12% | 68.12% | -276.57% | 322.22% | -113.98% |
| Cash from Operations | 76.10% | 33.85% | -2.56% | 31.73% | -186.66% |
| Capital Expenditure | 77.55% | -60.13% | 47.06% | -725.71% | 62.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 77.55% | -60.13% | 47.06% | -725.71% | 62.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 99.95% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 112.77% | -- | -- | -- | -- |
| Cash from Financing | -99.63% | 135,300.00% | 0.00% | 0.00% | -100.02% |
| Foreign Exchange rate Adjustments | -98.67% | 323.88% | -452.63% | 72.73% | 152.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.58% | 179.91% | -1.32% | 27.72% | -129.60% |